Cite Filings / ACRS / 0001306550-23-005155

Feed Companies Filings Check

Sign in

SC 13G/A

Amended Statement of Ownership

Aclaris Therapeutics, Inc. Filed 2023-01-31 Acc 0001306550-23-005155

Documents 1

SC 13G/A Amended Statement of Ownership , us00461u1051_013123.txt

Around this filing

2023-02-06 SC 13G/A Amended Statement of Ownership
2023-02-03 4 Director sold 30,000 shares at an average $16.66 ($499,923)
2023-02-03 4 Options or other derivatives
2023-02-03 4 Options or other derivatives
2023-02-03 4 Options or other derivatives
2023-01-31 SC 13G/A Amended Statement of Ownership
2022-02-15 SC 13G/A Amended Statement of Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading us00461u1051_013123.txt…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…